ACT Lung Health Intervention: Phase Two

Purpose

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Conditions

  • Smoking Cessation
  • Smoking Behaviors
  • Smoking, Tobacco
  • Smoking, Cigarette
  • Smoking (Tobacco) Addiction

Eligibility

Eligible Ages
Between 18 Years and 100 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-identify as either Chinese or Korean - Speak either Korean, Mandarin, or English - Are 18 years of age or older - Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days) - Will live in the United States for the next 12 months

Exclusion Criteria

  • Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months. - We will not include any of the following special populations: - Adults unable to consent. - Adults younger than 50 or older than 80 years - Individuals who are not yet adults (infants, children, teenagers) - Pregnant women - Prisoners

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Health Services Research
Masking
Double (Participant, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Group A: ACT Lung Health Intervention
Participants will be randomized 1:1 in blocks, stratified by ethnicity and readiness to quit smoking and will complete: - Baseline assessment - Eight telephone or video counseling sessions over 8 weeks - Nicotine replacement therapy (NRT) patches, gums and lozenges will be provided - Written educational materials on lung cancer screening will be provided - Assessments at 1, 3, and 6 months - 3 month saliva test - 6 month saliva test
  • Behavioral: ACT Lung Health Intervention
    An Asian culture-tailored lung health intervention, which includes individual counseling sessions, family coaching, provision of nicotine replacement therapy (NRT) in the form of patches, lozenges, or chewing gum, and educational materials about low-dose computed tomography (LDCT) for lung cancer screening. The eight weekly, counseling sessions with study staff will be conducted via phone call or the Zoom web-conferencing platform.
    Other names:
    • Asian Culturally Tailored Lung Health (ACT) Intervention
No Intervention
Group B: Standard Care
Participants will be randomized 1:1 in blocks, stratified by ethnicity and readiness to quit smoking and will complete: - Baseline assessment - Six telephone or video counseling sessions over 8 weeks - Nicotine replacement therapy (NRT) patches, gums and lozenges will be provided - Written educational materials on lung cancer screening will be provided - Assessments at 1, 3, and 6 months - 3 month saliva test - 6 month saliva test

Recruiting Locations

Dana-Farber Cancer Institute
Boston, Massachusetts 02115
Contact:
Mary Cooley, PhD
617-632-5096
Mary_cooley@dfci.harvard.edu

University of Massachusetts-Boston
Boston, Massachusetts 02125
Contact:
Sun Kim, PhD, RN
sun.kim@umb.edu

More Details

Status
Recruiting
Sponsor
Dana-Farber Cancer Institute

Study Contact

Mary Cooley, PhD
617-632-5096
mary_cooley@dfci.harvard.edu

Detailed Description

This two-arm stratified randomized clinical trial is to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer. Participants will be randomized into one of two groups: Group A: ACT Lung Health Intervention versus Group B: Standard Care. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, questionnaires, and saliva tests. It is expected participation in this study will last about 6 months. About 50 participants are expected to take part in this research study. The National Cancer Institute is providing funding for this trial.